On successful completion of the development, Mitsubishi will have exclusive manufacturing and sales rights in Japan and other Asian countries. “Japan constitutes a traditionally important market for Richter and the company has joined forces with various Japanese firms in the past in the framework of research and other agreements,” the announcement said.
The compound has entered Phase I trials in Japan. Richter noted that, as announced earlier, it already has a collaboration agreement for the development and sale of the same drug with Forest Laboratories Ireland, a unit of US-based Forest Laboratories.
Producing journalism that is worthy of the name is a costly business. For over 30 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
